Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

Press releases published on August 13, 2026

2 hours ago

Meet Pomoni: Physician-Founded Polyphenol Brand Unveils New Name, New Olive Oil Supplement for Athletes

Indeterminate GlobeNewswire

2 hours ago

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests

Indeterminate GlobeNewswire

2 hours ago

MapLight Therapeutics Announces $150 Million Private Placement Financing 

Indeterminate GlobeNewswire

3 hours ago

CurePSP Establishes Public Policy and Advocacy Team to Accelerate National Impact

Indeterminate GlobeNewswire

3 hours ago

Opción Yo Earns a Place Among the Top 3% of the Inc. 5000

Indeterminate GlobeNewswire

3 hours ago

Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth

Indeterminate GlobeNewswire

3 hours ago

Reese Consumer Health Acquires Topical Pain Relief Brand Australian Dream

Indeterminate GlobeNewswire

3 hours ago

Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness

Indeterminate GlobeNewswire

3 hours ago

PDS Biotech Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

SS Innovations Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Dogwood Therapeutics Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

3 hours ago

Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

4 hours ago

Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

4 hours ago

WallabyPhenox Announces First Patient Enrolled in PROMISE Study Evaluating Treatment of Medium Vessel Occlusion Stroke

Indeterminate GlobeNewswire

4 hours ago

Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update

Indeterminate GlobeNewswire

4 hours ago

Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results

Indeterminate GlobeNewswire

4 hours ago

Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients

Indeterminate GlobeNewswire

4 hours ago

QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program

Indeterminate GlobeNewswire

4 hours ago

Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement 

Indeterminate GlobeNewswire